Localization of Propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium

Modern Pathology

Volumn 25, Issue 9, 2012, Pages 1284-1297

  Negi, Mariko ^a   Takemura, Tamiko ^b   Guzman, Josune ^c   Uchida, Keisuke ^a   Furukawa, Asuka ^a   Suzuki, Yoshimi ^a   Iida, Tadatsune ^a   Ishige, Ikuo ^a   Minami, Junko ^d   Yamada, Tetsuo ^a   Kawachi, Hiroshi ^a   Costabel, Ulrich ^e   Eishi, Yoshinobu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

epithelioid cell granuloma; Hamazaki Wesenberg body; lipoteichoic acid; trigger factor protein

Indexed keywords

LIPOTEICHOIC ACID;

ARTICLE; BACTERIAL CELL; CELL WALL; CONTROLLED STUDY; ELECTRON MICROSCOPY; GERMANY; GRANULOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG BIOPSY; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; LYMPH NODE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM; TRANSBRONCHIAL BIOPSY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; GRANULOMA; HUMANS; LIVER; LYMPH NODES; PIGMENTS, BIOLOGICAL; PROPIONIBACTERIUM ACNES; RATS; RATS, SPRAGUE-DAWLEY; SARCOIDOSIS, PULMONARY;

EID: 84865702362     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.80     Document Type: Article

References (38)

1. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-173.
2. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003;361:1111-1118.
3. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004;170:1324-1330.
4. McGrath DS, Goh N, Foley PJ, et al. Sarcoidosis: genes and microbes-soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001;18:149-164.
5. du Bois RM, Goh N, McGrath D, et al. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med 2003;253:4-17.
6. Drake WP, Newman LS. Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med 2006;12:359-363.
7. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002;40:198-204.
8. Brownell I, Ram?́rez-Valle F, Sanchez M, et al. Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol 2011;45:899-905.
9. Drake WP, Dhason MS, Nadaf M, et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 2007;75:527-530.
10. Ebe Y, Ikushima S, Yamaguchi T, et al. Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:256-265.
11. Zumla A, James DG. Granulomatous infections: etiology and classification. Clin Infect Dis 1996;23: 146-158.
12. Homma JY, Abe C, Chosa H, et al. Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med 1978;48:251-255.
13. Abe C, Iwai K, Mikami R, et al. Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl Bakteriol Mikrobiol Hyg A 1984; 256:541-547.
14. Brincker H. Sarcoid reactions in malignant tumours. Cancer Treat Rev 1986;13:147-156.
15. Harlow E, Lane D. Monoclonal antibodies. In: Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory: New York, 1988, pp 139-281.
16. Minami J, Eishi Y, Ishige Y, et al. Pulmonary granulomas caused experimentally in mice by a recombinant trigger-factor protein of Propionibacterium acnes. J Med Dent Sci 2003;50:265-274.
17. Yamada T, Eishi Y, Ikeda S, et al. In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol 2002;198: 541-547.
18. WADE HW. A modification of the Fite formaldehyde (Fite I) method for staining acid-fast bacilli in paraffin sections. Stain Technol 1957;32:287-292.
19. Ito T, Kobayashi D, Uchida K, et al. Helicobacter pylori invades the gastric mucosa and translocates to the gastric lymph nodes. Lab Invest 2008;88:664-681.
20. Furukawa A, Uchida K, Ishige Y, et al. Characterization of Propionibacterium acnes isolates from sarcoid and non-sarcoid tissues with special reference to cell invasiveness, serotype, and trigger factor gene polymorphism. Microb Pathog 2009;46:80-87.
21. Fischer W, Koch HU, Haas R. Improved preparation of lipoteichoic acids. Eur J Biochem 1983;133:523-530.
22. Kumar V, Abbas A, Fausto N, et al. Granulomatous inflammation, In: Robbins and Cotran's pathologic basis of disease: 8th edn. Saunders: London 2010; pp, 73-74.
23. Moller DR. Potential etiologic agents in sarcoidosis. Proc Am Thorac Soc 2007;4:465-468.
24. Gupta D, Agarwal R, Aggarwal AN, et al. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 2007;30:508-516.
25. Swaisgood CM, Oswald-Richter K, Moeller SD, et al. Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide. Am J Respir Cell Mol Biol 2011;44: 166-174.
26. Ishige I, Usui Y, Takemura T, et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999;354:120-123.
27. Carr I. Sarcoid macrophage giant cells. Ultrastructure and lysozyme content. Virchows Arch B Cell Pathol Incl Mol Pathol 1980;32:147-155.
28. Okabe T, Suzuki A, Ishikawa H, et al. Cells originating from sarcoid granulomas in vitro. Am Rev Respir Dis 1981;124:608-612.
29. Moscovic EA. Sarcoidosis and mycobacterial L-forms. A critical reappraisal of pleomorphic chromogenic bodies (Hamazaki corpuscles) in lymph nodes. Pathol Annu 1978;13(Pt 2):69-164.
30. Boyd JF, Valentine JC. Unidentified yellow bodies in human lymph-nodes. J Pathol 1970;102:58-60.
31. Doyle WF, Brahman HD, Burgess JH. The nature of yellow-brown bodies in peritoneal lymph nodes. Arch Pathol 1973;96:320-326.
32. Alavi HA, Moscovic EA. Immunolocalization of cellwall-deficient forms of Mycobacterium tuberculosis complex in sarcoidosis and in sinus histiocytosis of lymph nodes draining carcinoma. Histol Histopathol 1996;11:683-694.
33. Ishige I, Eishi Y, Takemura T, et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:33-42.
34. Nishiwaki T, Yoneyama H, Eishi Y, et al. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am J Pathol 2004;165:631-639.
35. Miyazaki E, Ando M, Fukami T, et al. Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect? Clin Rheumatol 2008;27:1195-1197.
36. Park DJ, Woog JJ, Pulido JS, et al. Minocycline for the treatment of ocular and ocular adnexal sarcoidosis. Arch Ophthalmol 2007;125:705-709.
37. Baba K, Yamaguchi E, Matsui S, et al. A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics. Sarcoidosis Vasc Diffuse Lung Dis 2006;23:78-79.
38. Bachelez H, Senet P, Cadranel J, et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 2001;137:69-73.